Clinical Trials Directory

Trials / Conditions / Histiocytosis, Langerhans-Cell

Histiocytosis, Langerhans-Cell

7 registered clinical trials studyying Histiocytosis, Langerhans-Cell — 3 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationAdebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in
NCT06902792
Second Affiliated Hospital of Wenzhou Medical UniversityPhase 1
RecruitingBiomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis
NCT06197204
Assistance Publique - Hôpitaux de Paris—
Active Not RecruitingInherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
NCT04100408
Children's Oncology Group—
TerminatedReduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00618540
Masonic Cancer Center, University of MinnesotaPhase 2
UnknownCardiovascular Risk Factors and LCH in Adults
NCT00483925
Laikο General Hospital, Athens—
RecruitingAdult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
NCT04665674
Assistance Publique - Hôpitaux de Paris—
CompletedTreatment of Resistant Langerhans Cell Histiocytosis With ENBREL
NCT00048373
Baylor College of MedicinePhase 2